Please select the option that best describes you:
What is your preferred third-line therapy for metastatic colon cancer, RAS-WT, MSS, low TMB with no targetable alterations?
Are you using Fruquintinib, Regorafinib or Trifluridine + Tipiracil +bev?
Are you using Fruquintinib, Regorafinib or Trifluridine + Tipiracil +bev?